Related Experiment Video
Updated: Jan 28, 2026

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles
Published on: March 18, 2015
RNA exploits an exposed regulatory site to inhibit the enzymatic activity of PRC2
Qi Zhang1, Nicholas J McKenzie1, Robert Warneford-Thomson2,3
1Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
Abstract:
Polycomb repressive complex 2 (PRC2) is a histone methyltransferase that maintains cell identity during development in multicellular organisms by marking repressed genes and chromatin domains. In addition to four core subunits, PRC2 comprises multiple accessory subunits that vary in their composition during cellular differentiation and define two major holo-PRC2 complexes: PRC2.1 and PRC2.2. PRC2 binds to RNA, which inhibits its enzymatic activity, but the mechanism of RNA-mediated inhibition of holo-PRC2 is poorly understood. Here we present in vivo and in vitro protein-RNA interaction maps and identify an RNA-binding patch within the allosteric regulatory site of human and mouse PRC2, adjacent to the methyltransferase center. RNA-mediated inhibition of holo-PRC2 is relieved by allosteric activation of PRC2 by H3K27me3 and JARID2-K116me3 peptides. Both holo-PRC2.1 and holo-PRC2.2 bind RNA, providing a unified model to explain how RNA and allosteric stimuli antagonistically regulate the enzymatic activity of PRC2.
Insights
Polycomb repressive complex 2 (PRC2) binds RNA, inhibiting its activity. This inhibition is reversed by specific peptides, revealing how RNA and these signals control PRC2 function.
Area of Science:
- Epigenetics and Gene Regulation
- Molecular Biology
- Chromatin Biology
Background:
- Polycomb repressive complex 2 (PRC2) is crucial for maintaining cell identity by regulating gene expression through histone methylation.
- PRC2 exists in different holo-complexes (PRC2.1 and PRC2.2) with varying accessory subunits.
- The mechanism of RNA-mediated inhibition of PRC2's enzymatic activity is not well understood.
Purpose of the Study:
- To elucidate the mechanism of RNA-mediated inhibition of holo-PRC2 complexes.
- To identify the RNA-binding sites on PRC2.
- To understand how RNA and allosteric activators interact to regulate PRC2 activity.
Main Methods:
- In vivo and in vitro protein-RNA interaction mapping.
- Biochemical assays to study allosteric regulation.
- Comparative analysis of human and mouse PRC2 complexes.
Main Results:
- An RNA-binding patch was identified on the allosteric regulatory site of human and mouse PRC2, near the methyltransferase center.
- RNA binding inhibits holo-PRC2 activity.
- Allosteric activation by H3K27me3 and JARID2-K116me3 peptides relieves RNA-mediated inhibition.
- Both holo-PRC2.1 and holo-PRC2.2 complexes bind RNA.
Conclusions:
- A unified model explains the antagonistic regulation of PRC2 enzymatic activity by RNA and allosteric stimuli.
- The findings provide insights into how different PRC2 holo-complexes are regulated in response to cellular signals.
- This study clarifies the role of RNA in modulating PRC2 function during development and differentiation.
Related Concept Videos
Cis-regulatory Sequences
Cis-regulatory Sequences
Feedback Inhibition
Inhibition of Cdk Activity
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors

